Prostate Cancer - Results from #21660

Prostate MRI: Can we do without DCE sequences in 2013? - Abstract December 6, 2013

Similar relationship between the time course of bone mineral density improvement and vertebral fracture risk reduction with denosumab treatment in postmenopausal osteoporosis and prostate cancer patients on androgen deprivation therapy - Abstract December 6, 2013

Evaluating long-term patient-centered outcomes following prostate cancer treatment: Findings from the Michigan Prostate Cancer Survivor study - Abstract December 6, 2013

Patient-centered perspectives on the access to educational opportunities specific to lifestyle modification in men at risk for primary or secondary prostate cancer - Abstract December 6, 2013

The role of magnetic resonance imaging in focal therapy for prostate cancer: Recommendations from a consensus panel - Abstract December 6, 2013

Cross-cultural application of the Korean version of the European Organization for Research and Treatment of Cancer Quality of Life Questionnaire for patients with prostate cancer - EORTC QLQ-PR25 - Abstract December 6, 2013

The lack of predictors for rapid progression in prostate cancer patients receiving sipuleucel-T - Abstract December 6, 2013

Treatment patterns and characteristics of European patients with castration-resistant prostate cancer - Abstract December 5, 2013

A urologic oncology roundtable discussion: How to choose among the available therapies for the treatment of castration-resistant prostate cancer - Abstract December 5, 2013

Cabozantinib: A novel agent with a dual mechanism of action for castration-resistant prostate carcinoma - Abstract December 5, 2013

The hurdle of antiandrogen drug resistance: Drug design strategies - Abstract December 5, 2013

Progression of intracranial meningioma during luteinizing hormone-releasing hormone agonist treatment for prostate cancer: Case report - Abstract December 4, 2013

Exploring the potential of [11C]choline-PET/CT as a novel imaging biomarker for predicting early treatment response in prostate cancer - Abstract December 4, 2013

Methods and rationale used in a matched cohort study of the incidence of new primary cancers following prostate cancer - Abstract December 4, 2013

Prostate cancer tumour features on template prostate-mapping biopsies: Implications for focal therapy - Abstract December 4, 2013

EAU guidelines on prostate cancer. Part 1: Screening, diagnosis, and local treatment with curative intent-update 2013 - Abstract December 4, 2013

Intensity-modulated radiotherapy versus radical prostatectomy in patients with localized prostate cancer: Long-term follow-up - Abstract December 4, 2013

Patient-reported outcomes in randomised controlled trials of prostate cancer: Methodological quality and impact on clinical decision making - Abstract December 4, 2013

Return to work and sick leave after radical prostatectomy: A prospective clinical study - Abstract December 3, 2013

Moderately hypofractionated radiotherapy for localized prostate cancer: Long-term outcome using IMRT and volumetric IGRT - Abstract December 3, 2013

Page 1084 of 1435